Table 1 Annual budgets, provided by the Thai National Health Security Office between 2019 and 2022, for prophylactic or on-demand home treatment using clotting factor concentrates in Thai children and adults with hemophilia
From: Practices and challenges for hemophilia management under resource constraints in Thailand
Disease severity | Hemophilia A | Hemophilia B | ||
|---|---|---|---|---|
Annual budgets per patient | Estimated reimbursable SHL FVIII concentrate units per patient (IU per year) | Annual budgets per patient | Estimated reimbursable SHL FIX concentrate units per patient (IU per year) | |
Budgets provided by the Thai National Health Security Office | ||||
Children below 10Â years of age | ||||
Severe hemophilia | 288,000 THB (8180 USD) | 28,500–46,000 | 226,800 THB (6240 USD) | 17,500–18,500 |
Moderate hemophilia | 144,000 THB (4090 USD) | 14,500–23,000 | 151,200 THB (4300 USD) | 11,500–12,000 |
Mild hemophilia | 36,000 THB (1025 USD) | 3750–5750 | 75,600 THB (2150 USD) | 5500–6000 |
Children above 10Â years of age and adults | ||||
Severe hemophilia | 345,600 THB (9830 USD) | 34,500–55,500 | 302,400 THB (8590 USD) | 23,000–24,000 |
Moderate hemophilia | 144,000 THB (4090 USD) | 14,500–23,000 | 151,200 THB (4300 USD) | 11,500–12,000 |
Mild hemophilia | 72,000 THB (2050 USD) | 7500–11,500 | 75,600 THB (2150 USD) | 5500–6000 |